Other hemoglobinopathies
ICD-10 D58.2 is a billable code used to indicate a diagnosis of other hemoglobinopathies.
Other hemoglobinopathies encompass a range of genetic disorders characterized by abnormal hemoglobin production, leading to various clinical manifestations, including hemolytic anemias. These conditions can arise from mutations in the globin genes, resulting in structural abnormalities of hemoglobin molecules. Common examples include thalassemias, where there is a reduced production of one or more globin chains, and sickle cell disease, which is caused by a single amino acid substitution in the beta-globin chain. Enzyme deficiencies, such as glucose-6-phosphate dehydrogenase (G6PD) deficiency, can also lead to hemolytic anemia, particularly under oxidative stress. The clinical presentation of hemoglobinopathies can vary widely, from asymptomatic carriers to severe anemia requiring transfusions. Diagnosis typically involves hemoglobin electrophoresis, complete blood counts, and genetic testing to identify specific mutations. Management strategies may include supportive care, blood transfusions, and in some cases, gene therapy. Understanding the genetic basis and clinical implications of these disorders is crucial for effective treatment and management.
Detailed lab results, genetic testing outcomes, and treatment plans.
Management of patients with diagnosed hemoglobinopathies, monitoring for complications.
Ensure accurate documentation of the specific type of hemoglobinopathy and any associated conditions.
Family history, genetic test results, and counseling notes.
Genetic counseling for families with a history of hemoglobinopathies.
Documentation must clearly outline the genetic basis of the condition and implications for family members.
Used to evaluate anemia in patients suspected of having hemoglobinopathies.
Document the reason for the CBC and any relevant clinical findings.
Hematology specialists should ensure that all relevant lab results are included.
Hemoglobinopathies are genetic disorders caused by abnormalities in the structure or production of hemoglobin, leading to various clinical manifestations, including anemia and increased risk of hemolysis.
D58.2 is used for other hemoglobinopathies not specifically classified under thalassemia (D56) or sickle-cell disorders (D57). It encompasses a broader range of conditions.
